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ABSTRACT 
Background: Human immunodeficiency virus (HIV) and hepati- 
tis B and hepatitis C viruses have emerged as major blood- 
borne infections. Several cases of infections through the use 
of unsterile injection needles also are on record. Kala-azar, or 
visceral leishmaniasis, is a hemoparasitic disease caused by 
Leishmania donovani. All the anti-kala-azar medications require 
multiple intramuscular injections of the anti-leishmanial drugs. 
To find whether these patients were at higher risk of contracting 
blood-borne infection, than those who were not on medication, 
a community-based study was conducted in the kala-azar- 
endemic state of Bihar, India. 
Methods: Five villages (4050 families) of three highly endemic 
districts of Bihar were included in this study. The sociodemo- 
graphic data of the affected families and their annual income 
were determined as per Government of India guidelines. The 
diagnosis of kala-azar and its sequelae, post-kala-azar dermal 
leishmaniasis (PKDL), was made, and their therapeutic details 
were noted. All the leishmania-infected patients, their spouses, 
family members, and villagemates were tested for hepatitis B 
surface antigen, hepatitis C virus antibodies, and anti-HIV (1 + 2) 
antibodies, using commercially available kits. 
Results: Of the 4050 families, 61 (1.5%) were found affected 
with kala-azar or PKDL. These 61 families had 77 cases of 
leishmaniasis, of which 64 (83%) had kala-azar and 13 (17%) 
PKDL. The most affected (4.5%) age group was 11 to 40 years. 
Of the 61 families, 57 (93.4%) families belonged to so-called 
untouchable castes, and 9 of them could not afford to have any 
anti-kala-azar treatment. Only 64 patients received treatment 
in the form of injectables. The number of injections received by 
these patients ranged from 3 to 120. Hepatitis B and C viral 
infections were found to be significantly more prevalent in those 
who received multiple injections. Compared to their male coun- 
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terparts infected with L. donovani, females who received 
injectable medicines were at higher risk of contracting hepati- 
tis B infections (20% vs. 11.3%) and hepatitis C virus infection 
(26.7% vs. 18.9%). Overall, hepatitis C virus infections were 
more common (20.6%) than hepatitis B virus infection (13.2%) 
in this group of patients. Villagemates with a history of injec- 
tions for other ailments also were found to have a high rate of 
infection with hepatitis viruses. One patient with kala-azar was 
found to be co-infected with HIV, although probably not related 
to injections. 
Conc/usions: The treatment of Indian kala-azar and post-kala- 
azar dermal leishmaniasis consists of multiple intramuscular 
injections of sodium stibogluconate, pentamidine, or ampho- 
tericin 6. Though the original disease gets cured, all these ther- 
apeutic regimens were found to carry a significantly high risk 
of transmitting yet more dangerous blood-borne infections, 
such as HIV and hepatitis B and C viruses, through the shared 
use of unsterile injection needles. All needles should be appro- 
priately sterilized, if they are to be re-used. 
Key Words: AIDS, amphotericin B, blood-borne infections, 
circumcision, India, pentamidine, sodium antimony gluconate, 
untouchable castes in India 
Int J Infect Dis 2000; 4:203-208. 
Kala-azar is a parasitic disease caused by a hemoflagellate 
Leishmania donovani. The infection is transmitted pri- 
marily from infected person to uninfected through the 
bites of a tiny insect (sandfly).’ Occasional reports of 
transmission through infected blood transfusion and the 
transplacental route are also on record.lm3 Kala-azar is 
characterized by prolonged fever with or without double 
peaks, anemia, loss of appetite and weight, and gross 
hepatosplenomegaly. If untreated, the peculiarity of Indian 
kala-azar is that the skin of patient becomes darker. Thus, 
the derivation of the name-kala (blackening) azar (fever).’ 
The infection produces only mild toxic symptoms; how- 
ever, severe weight loss, anemia, and some systemic 
impairment, may result in death. Fatalities are more com- 
mon in children and females from poor families. Some of 
the successfully treated cases of kala-azar develop its cuta- 
neous manifestation in the form of hypopigmentation 
with or without maculopapular lesions on the skin. This 
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sequala is seen a few months or years after treatment of 
or spontaneous recovery from kala-azar or sometimes 
during treatment; hence it is known as post-kala-azar der- 
ma1 leishmaniasis (PKDL). 
The disease is endemic in northeastern parts of India, 
along the Ganges river, mainly in the state of Bihar,‘-’ 
which is one of the poorest provinces of the country. It 
causes loss of thousands of lives and prolonged morbid- 
ity, with severe economic consequences. 
All the accepted therapeutic regimens for both pri- 
mary and secondary manifestations consist of multiple 
intramuscular injections either of sodium antimony glu- 
conate (SAG), pentamidine, or amphotericin B.*-’ Since 
the health services in India are offered by the state gov- 
ernments, it is not possible for the state health depart- 
ment to provide disposable injection needles to all 
patients. The authors previously have reported co-infec- 
tion of Leishmaniu with human immunodeficiency virus 
(HIV),* and HIV infection through unsterile injection nee- 
dles used by roadside quacks.” Several studies have been 
published on the spread of HIV through the re-use of 
injection needles.3 Druce et al found that even after sev- 
eral (6) washings with water, HIV can be isolated from 
the syringes contaminated with HIV-infected blood.” 
However, such studies have provided much less data on 
the transmission of hepatitis B and C viruses (HBV and 
HCV), and to the authors’ knowledge, no study of the sit- 
uation in India has been published to date. Hepatitis B 
viral infection is one of the most serious chronic infec- 
tions. About 200 million people are infected with this 
virus, most of them in the developing nations, including 
India.“%‘* Approximately 5 to 10% of chronic carriers 
develop cirrhosis of the liver, which carries a high rate 
of mortality. Unlike HBV, the true gravity of HCV infection 
is yet to be determined; however, in one study it was 
established that 50% of the HCV-infected people will 
develop hepatocellular carcinoma (HCC).13 
This study was undertaken to find the prevalence 
rates of HBV, HCV, and HIV among patients with kala-azar 
and PKDL who receive intramuscular injections of the 
anti-kala-azar drugs and their family members, to examine 
the possibility of intrafamilial transmission of these 
viruses. The prevalence rate of these infections in some 
additional categories of people (immediate neighbors and 
other villagemates of the index patients) with and with- 
out a history of multiple injections for other illnesses also 
was studied, for comparison. 
MATERIALS AND METHODS 
Study Areas 
The present field-based study was carried out in five vil- 
lages of districts Vaishali, Samastipur, and Shahibganj, in 
the state of Bihar, India. In view of the nonavailability of 
a sampling frame, which is essentially a list or form of 
identification of the local residents to be sampled, as well 
as the considerable work involved in the community lab 
oratory, the villages were selected based on their ranking 
in terms of number of patients with leishmaniasis. The 
prevalence in the selected five villages was: 9 cases among 
a population of 1254 (718/100,000) and 2 deaths in 
Sirdilpur; 14 cases among a population of 12,805 
(1 lO/lOO,OOO) in Patori; 30 cases among a population of 
6100 (491/100,000) and 6 deaths in Jorpura; 19 cases 
among a population of 2510 (757/100,000) and 3 deaths 
in Phulbhanga; and 5 cases among a population of 3004 
(166/100,000) and 1 death in Panchgarh village. These fig- 
ures were considered alarming by the Governments of 
Bihar state and India, and special medical teams from the 
National Institute of Communicable Diseases (NICD) and 
other state administrative agencies were sent to study 
the epidemic. The NICD is a nodal agency between the 
federal government and state governments for collecting 
data and implementing the government schemes on kala- 
azar and other infectious diseases. 
Socioeconomic Data 
Demographic details of these villagers were collected by 
interviewing people in them individually Their castes (as 
per the Indian caste system, see Table 1, legend) were 
determined according to the voter list approved by the 
Election Commission of India. For economic classifica- 
tion, guidelines of the Government of India were fol- 
lowed.‘* In brief, poverty is the most obvious problem of 
India. According to 1987 to 1988 estimates, about 29.9% 
(237.7 million) of the population of the country is living 
below the poverty line of which 82.5% (196 million) are 
in rural areas. The poverty line is defined as the expen- 
diture required for a daily calorie intake of 2400 per per- 
son in rural areas and 2100 in urban areas. According to 
the 1991- 1992 prices (which by now have increased dra- 
matically), group households that have a total family 
income of Rs. 20,000 (U.S.$500) per annum are classi- 
fied as low income, Rs. 20,000 to 62,000 (U.S.$500-1500) 
per annum as middle income, and more than Rs. 62,000 
(U.S.$1500) per annum as high income households.‘* 
Diagnosis of Kala-Azar, History 
of Injectables, and Blood Sampling 
All the local residents of these villages were first clini- 
cally examined by one of the authors (SS). The diagnosis 
of kala-azar was made by serologic tests and confirmed 
by parasitologic examination.1-2 The kala-azar patients 
were then identified, and informed consent was obtained 
to take their blood samples for further testing of various 
infections, including HIV HBV and HCV Some spouses, 
family members, and immediate neighbors as well as 
other villagemates of these kala-azar patients were coun- 
selled, and their blood samples were collected in plain 
vials for these serologic investigations. History and the 
number of injections received by these persons for 
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kala-azar or other ailments also were noted. Sera were 
separated and transported by air to All India Institute of 
Medical Sciences and stored at -20°C until use. 
Viral Studies 
Antibodies against HIV (1 + 2) were detected using the 
Innotest EL4 kit (Irmogenetic, N.V, Belgium), and the reac- 
tive cases were retested three times and fmally confirmed 
by Western blot. For detection of HBV infection, the 
HBsAg EL4 screening kit was used (General Biologicals 
Corp., Taiwan), and results were confirmed by using 
another EIA kit (OrthoTM Diagnostic Systems GmbH, Ger- 
many). The test was performed as per manufacturer’s 
guidelines provided in the kit insert. Anti-HCV antibodies 
were detected by ready-to-use third generation (v-3) EIA 
kit (Core, NS-3, NS-4, & NS-5 antigens) BioChem 
ImmunoSystems DETECT-HCV (BioChem Immuno- 
Systems Inc., Montreal, Canada) and positive sera were 
repeat tested with OrthoTM HCV 3.0 ELISA (Ortho Diag- 
nostic Systems). During the tests strict guidelines of the 
manufacturer were adopted. 
Statistical Analysis 
Since outcome is recorded on a nominal scale, results are 
described in various categories using “proportion or per- 
centage.“Association and homogeneity of the prevalence 
rates of HBV, HCV, HIV, and leishmaniasis between any 
two categories of the persons was compared through 
chi-squared test (withyates’ correction).‘5 When assump- 
tion of this test was not found appropriate, Fisher’s exact 
test was used.15 The relative risk (estimated as odds ratio 
[OR]) of infections among all those with leishmaniasis 
who received injectable drugs versus those who did not 
receive injectable anti-leishmanial drugs, or those who 
received injectable drugs other than anti-leishmanials for 
other ailments together with others who did not receive 
any injectables, with respective 95% confidence interval 
(CI) also was calculated. A level of significance less than 
5% (P < 0.05) was considered as significant.15 
RESULTS 
Kala-Azar and Social Setup 
A thorough survey of the five villages of the three most 
affected districts was conducted (Table 1). The rate of infec- 
tion with L. donovani in Hindu undivided families of these 
villages ranged from 0.6% to 8.0%. The number of affected 
persons ranged from none to as many as four patients in 
a family. Sixty-one families, comprised of 230 individuals 
(141 male, 89 female) were identified as affected. The age 
group most often affected was 11 to 40 years. The rate of 
infection was more (P < 0.05) in so-called lower caste fam- 
ilies (2.6%) compared to those of upper castes (0.2%). Also, 
a higher rate of infection (2.9%) was noted among families 
who had a low income compared to those with middle 
and high income (P < 0.05). The number of kala-azar or 
PKDL cases among 61 affected families was 77; and of 
them 64 had visceral leishmaniasis and 13 had PKDL. Only 
68 patients had received anti-leishmanial treatment, and 9 
could not afford to have any treatment, owing to extreme 
poverty. Of the 68 patients undergoing anti-leishmanial 
treatment, 64 had received full or partial treatment with 
sodium antimony gluconate (SAG). One was treated with 
pentamidine and 11 with amphotericin B. An interesting 
finding of this study was the difference in responsiveness 
to the sodium stibogluconate among various village pop 
ulations. Among the three districts, highest drug resistance 
was observed in Samastipur, followed by Vaishali (data not 
shown). However, the usual course of SAG was 100% effec- 
tive in the villages of Shahibganj district. 
Hepatitis Viruses in Kala-azar Patients 
All three blood-borne viral infections were significantly 
higher in kala-azar or PKDL index cases. Persons with 
Table 1. Demographic Details of the Families of Bihar Affected with Visceral Leishmaniasis* 
Families 
Caste+ Fami/y home 
District Affected W--r Lower High Middle Low 
Village 6114050 (7.5%) 411850 (O.Z%j 571’2200 (2. S%j O/60 (0. O%j 4/2050 (0.2%) 57/7940 (2.9%j 
Vaishali 
Sirdilpur 5/200 (2.5) Oh0 (0.0) 5/l 50 (3.3) o/o (0.0) O/50 (0.0) 5/l 50 (3.3) 
Samastipur 
Patori 12/2000 (0.6) 2/1100 (0.18) o/900 (0.0) o/50 (0.0) 2/l 000 (0.2) 1 o/950 (1 .O) 
Jorpura 2511200 (2.0) 2ROO (0.2) 23/500 (4.6) O/l 0 (0.0) 2/600 (0.3) 23/590 (3.8) 
Shahibganj 
Phulbhanga$ 15/600 (2.5) o/o (0.0) 15/600 (2.5) o/o (0.0) O/400 (0.0) 15/200 (7.5) 
Panchgarh 4150 (8.0) o/o (0.0) 4/50 (8.0) o/o (0.0) o/o (0.0) 4/50 (8.0) 
*Figures presented are as numbers of affected/total number of families. Figures in parenthesis are percentage of affected families. 
tAGcording to Indian mythology (Chaturvarna). all Hindus are divided into four main castes or varnas. Three varnas (Brahmin, Kshatriya, and Vaishya) are designated 
as upper castes, and the fourth varna (so-called Shudra) is lowest. The lower castes thus formed include, backward castes, scheduled castes, and scheduled tribes. 
The latter two groups are considered as atishudra or untouchables, and they live in the least hygienic conditions and on the outskirts of the rural villages. Their main 
livelihood is derived from working for upper caste landlords, in the form of farming, cattle raising, and domestlc help, 
$90% of population belonged to Muslrm religion. 
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Table 2. Hepatitis 6 and C Markers in Indian Patients with Leishmaniasis and Their Spouses or Family Members or Villagemates* 
I /I 
Patient Group 
111 IV (I + 111) V Total 
Hepatitis B surface antigen 
Male 6/53 (11.3) o/7 (0.0) 2/62 (3.2) 2/69 (2.9) 2/19 (10.5) 10/141 (7.1) 
[Indeterminant] [3.8(0.7-28.9) [1.1(0.2-8.7)] [l. 1(0.2-1.8)] 
Female 3/l 5 (20.0) o/2 (0.0) O/52 (0.0) Oh4 (0.0) 2/20 (10.0) 5/89 (5.6) 
[Indeterminant] [Indeterminant] [Indeterminant] [2,3(0.3-23.4)] 
Total 9/68 (13.2) o/9 (0.0) 2/l 14 (1.8) 2/123 (1.6) 4/39 (10.3) 15/230 (6.5) 
[Indeterminant] [8.5(1.6-59.3)] [9.2(7.8-64.0)] [1.3(0.3-5.6)] 
Anti-HCV antibodies 
Male 1 O/53 (18.9) O/7 (0.0) 3/62 (4.8) 3/69 (4.3) l/l 9 (5.3) 14/l 41 (9.9) 
[Indeterminant] [4.6(1.1-22.4)] [5.1(1.2-25.0)] [4.2(0.5-93.8) 
Female 4/l 5 (26.7) o/2 (0.0) 2/52 (3.8) 2/54 (3.7) 2/20 (10.0) 8/89 (9.0) 
[Indeterminant] [9.1(1.2-83.9)] [9.5(7.2-87. l)] [3.3(0.4-31.6)] 
Total 14/68 (20.6) o/9 (0.0) 5/l 14 (4.4) Ed123 (4.1) 3139 (7.7) 22/230 (9.6) 
[Indeterminant] [5.7(1.8-19. l)] [6s. 1(1.9-20.6)] [3.1(0.8-14.8)] 
*Number positive/number tested (%) and [odds ratio (95% confidence inter!@] of hepatitis markers among group I of patients compared to respective groups. 
I: Leishmaniasis patients with history of injectable anti-leishmanial drugs. 
II: Leishmaniasis patients with no history of injectable medication in last 2 years. 
III: Spouses, family members, and villagemates of the index cases with no history of injections in past 2 years. 
IV Leishmaniasis patients, their spouses, family members, and villagemates with no history of injections in past 2 years. 
V: Spouses, family members, and villagemates of the index cases with history of injections for other ailments. 
leishmaniasis who received injectable anti-leishmanial 
drugs had a significantly higher risk of HBV infection 
compared to all those who did not receive injectable anti- 
leishmanial drugs (OR = 9.2; CI = 1.8-64.0) though their 
number was small gable 2). Gender-specific analysis of 
the results showed that men were at higher risk, but the 
difference was not statistically significant (OR = 1.1; 
CI = 0.2-l .8). However, HCV infection was more common 
in both men (OR = 5.1; CI = 1.2-25.0) and women 
(OR = 9.5; CI = 1.2-87.1) who received injectable anti- 
leishmanial drugs. Patients with leishmaniasis with a his- 
tory of injectable anti-leishmanial drugs had more chance 
of getting hepatitis viruses than their spouses or family 
members and villagemates with a history of injections 
for other ailments (P < 0.05). The study also evaluated the 
effect of the number of injections of drugs in acquiring 
these blood-borne infections. To arrive at this conclusion, 
the dose of injections was divided into two categories: 
(1) those who received less then 40 injections of SAG 
(an extended regimen suggested by the World Health 
Organization [WHO])2 and (2) those who received more 
than 40 injections for various reasons, such as recurrences 
of kala-azar in preceding years, in a treatment regimen 
received from doctors and non-doctor practitioners who 
did not follow the WHO protocol. Thirty-eight patients 
(29 males and 9 females) received 40 or fewer injections. 
Of these, two males and two females were positive for 
HBs antigen and four males and two females for anti-HCV 
antibodies. However, no patient in this group had co- 
infection of HBV and HCV In the second category, 30 
patients (24 males and 6 females) received more than 40 
injections, including one male patient who had received 
20 injections of SAG every year for the previous 6 years. 
Of these, four males and one female were positive for 
HBV and six males and two females were positive for 
HCV antibodies. Only one male patient from the village 
of Phulbhanga, in this group showed co-infection of HBV 
and HCV Thus, for HBV infection, for those who received 
more than 40 injections compared to those who received 
less than 40 injections, OR = 2.7 (CI = 0.4-23.9); OR = 0.7 
(CI = 0.0-15.9); and OR = 1.7 (CI = 0.4-8.6)respectively 
for men, women, and men and women as a group. For 
HCV infection, OR = 2.1 (CI = 0.4-10.6); OR = 1.8 
(CI = 0.1-3 1.1); and OR = 1.9 (CI = 0.5-7.5) respectively 
Although leishmaniasis was more common in males 
than females (60/141 vs. 17/89) a similar pattern was not 
observed for blood-borne infections. Further, the figures 
indicate that injectable medication was the single largest 
risk factor for these infections (see Table 2). Because of 
small sample size, it was not possible to obtain data on 
risk related to sexual transmission of hepatitis viruses in 
these patients, but it was significant to find HCV infection 
in one spouse with no other risk factor. Viiagewise preva- 
lence indicated that prevalence of hepatitis B surface anti- 
genemia was not significantly different among these 
villages but anti-HCV antibodies were highest (35.7%) in 
Phulbhanga. An interesting finding in this village was six 
patients with PKDL out of 600 families with a total pop- 
ulation of 2510. There were four cases in one family and 
two in another. This village is dominated by a cult of Mus- 
lims (see Table 1). 
Leishmania and HIV Co-infection 
There was only one male patient found positive for HIV 
infection. This patient contracted HIV-l from a female 
sex worker in Bombay when he visited the city in search 
of employment. Within 1 month of having unprotected 
sex with CSW, while still in Bombay (a kala-azar non- 
endemic area), he developed fever that did not come 
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down with the administration of antibiotics and anti- 
malarials. No malaria parasites were seen in his blood and 
no bacteria was isolated from any body fluid. However, 
in routine screening, he was found to be positive for anti- 
HIV antibodies. He returned to his native place in Bihar, 
where he was treated with several oral and injectable 
medicines, but without any improvement. In the mean- 
time he also developed weakness, wasting, and spleno- 
megaly. He was referred to the All India Institute of 
Medical Sciences, New Delhi, where his splenic aspirate 
was found to be positive for L. donovani bodies. He was 
treated successfully with sodium antimony gluconate. 
DISCUSSION 
The risk of acquiring blood-borne infections was signifi- 
cantly high in patients with kala-azar under medication. 
Kala-azar is treated with injections of sodium antimony 
gluconate, pentamidine, or intravenous amphotericin B. 
The latter two drugs are injected or infused after hospi- 
talization of the patients, but SAG is supplied free of cost 
by the Government of India through the state governed 
dispensaries or primary health centers and issued to the 
rural health care workers. These health care workers pay 
home visits to the infected patients and inject 3 to 5 mL 
SAG daily intramuscularly. The difference in rate of infec- 
tion in SAG-treated versus other groups (as seen in Table 
2) was significant (P < 0.05) the difference also was sig- 
nificant between those who received SAG and those who 
received other injectable drugs for other ailments. This 
difference could be explained by the lack of adherence 
to the practice of sterilization by the health care work- 
ers who inject these government-supplied medicines. It 
is common practice that a single needle is re-used repeat- 
edly after cleaning it in hot or warm water. The time and 
temperatures for boiling these needles and syringes is 
not critically observed. The present cohort study strongly 
suggests that re-use of these injection needles in this fash- 
ion could result in transmission of hepatitis B and C 
viruses.‘6.‘7 Often if not always, these injections are given 
as an obligation and not as the right of the patients with 
leishmaniasis who are the socially neglected poor and 
cannot ask these health care workers to use sterile nee- 
dles or even to boil the syringes and needles properly Dis- 
regard for sterilization is furthered by the unawareness 
about transmission of infections through injection needles 
in both the health care workers and the receiving 
patients. Those who receive injectable medicines for 
other illnesses seek medical aid from private physicians 
or from government hospitals, where sterilization facili- 
ties are comparatively better and these services are pro- 
vided on payment or under direct medical supervision, 
respectively 
It is important to mention that HBV and HCV mainly 
are considered as major causes of blood transfusion-asso- 
ciated hepatitis (TAH), hence most of the studies carried 
out in India report the seroprevalence rate of these infec- 
tions only in professional or voluntary blood donors. No 
major study has been carried out on apparently healthy 
Indians. In a developing country such as India, where 
even the major blood banks have meagre resources to 
screen all the blood samples and several thousand units 
of hepatitis C-unscreened blood is being transfused, study- 
ing the common people particularly of a poor state like 
Bihar is only a dream. Therefore, due to lack of such data 
from this state on either hepatitis B or C, the prevalence 
rates cannot be compared. However, studies carried out 
from other parts of the country, using a second-genera- 
tion EL4 detection kit, indicate that the seroprevalence 
rate of HCV in blood donors in northwestern India in 
1992 was between 0.5% and 2.5%,18 but using more sen- 
sitive third-generation kits, the detection rate even in vol- 
untary blood donors from the same region has gone up 
to 4%.‘9 
Hepatitis B infection, also has been established as a 
sexually transmitted disease,*O but sexual mode of HCV 
infection is controversial. *’ However, recently many 
patients with sporadic or community-acquired hepatitis 
with no history of exposure to blood products also have 
been found to have HCV infection.** Other studies have 
reported high seroprevalence of anti-HCV antibodies in 
sexual partners of HCV carriers, indicating sexual trans- 
mission of this virus in the same manner as of hepatitis 
B virus. More recently, a high seroprevalence rate of 30% 
has been reported in leprosy patients in India, using a 
third-generation EL4 kit, suggesting transmission through 
contacts.z2,23 It is postulated that HCV colonizes on the 
skin and subsequently enters through abrasions or micro- 
scopic injuries in the skin. The present findings of high 
seroprevalence of HCV infection in Phulbhanga village 
where PKDL was a major health problem supports this 
hypothesis. The findings of this village under the juris- 
diction of district Shahibganj, were unusual in that mem- 
bers of a particular religion showed a higher prevalence 
rate of PKDL form of leishmaniasis and of anti-HCV anti- 
bodies (35.7%) than any other group studied (see Table 
1, legend). Kiyosawa et al in 1991 reported a high rate of 
familial transmission of HCV infection in Japan.*l How- 
ever, they did not specify any risk factors and possible 
source of infections. However, in the present study, it is 
important to mention that in 19 cases of leishmaniasis in 
Phulbhanga six had PKDL, and all of these had maculo- 
papular lesions and serosanguinous discharge from the 
lesions, which is not an infrequent sequela. All these six 
cases were from two families (4 + 2) and all the four 
PKDL-affected members of a family were positive for anti- 
HCV Therefore, this familial outbreak can be explained in 
three ways. First, the patients all had PKDL, and most 
likely the same needle was used simultaneously by the 
health care workers, and thus, all contracted this viral 
infection through injection needles. Second, it is common 
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practice in rural India that the close associates and fam- 
ily members care for each other by scratching their backs 
during attacks of itching. Sharing of razors and cloths is 
common. Therefore, it was not unlikely that these socio- 
cultural habits might have resulted in the high transmis- 
sion rate of HCV in this family and village. Third, but not 
less importantly, it is also possible that male Muslims (see 
Table 1) might have acquired this infection during their 
circumcision, a religious tradition of excising the pre- 
puce. This traditional operation is done inside the house- 
holds under most primitive hygienic conditions by a 
religious priest, re-using the same blade. However, the 
findings of this study could not significantly be corrobo- 
rated to suggest sexual transmission of hepatitis viruses. 
Regarding HIV and leishmanial co-infection, ample 
studies from India and abroad have been carried out, 
reporting comparatively more severe clinical manifesta- 
tions of kala-azar and also of HCV infection in those indi- 
viduals who are co-infected with HlVF* However, there 
is no documentation indicating that anti-kala-azar treat- 
ment can lead to high transmissibility of another infection 
while curing the one. The sequence of events in the sole 
case of L. donovuni and HlV co-infection indicate that this 
patient was suffering from subclinical infection of Leish- 
mania that was acquired in Bihar. Later, he contracted 
HIV infection in Bombay and the disease presented as 
first clinical manifestation. However, unlike HIV infection 
high seroprevalence of hepatitis viruses in this state, one 
may predict that in some situations a reverse phenome- 
non may occur, that is, if the diagnosis of kala-azar is made 
first and the patient is treated for kala-azar without test- 
ing for HlV antibodies (a common practice in Bihar), the 
treatment may spread HN to other patients. This mode 
of transmission for all the blood-borne infections is 
expected more in those who are treated by several doc- 
tors. In another study, 33.5% of patients with kala-azar 
hospitalized in Delhi hospitals after receiving treatment 
from various doctors outside Delhi (mainly Bihar) were 
found to be positive for hepatitis B antigen, compared to 
only 2% seroprevalence in those who received injectable 
treatment only in Delhi (details not shown). These stud- 
ies also indicate that once an infection is established in 
the society, anti-kala-azar therapy may lead to horizontal 
transmission, of all blood-borne infections including HIV. 
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